I am not inclined to defend James. I am pretty convinced that he is out of his depth. none of that changes that the pedigree of this discovery is vastly different than a typical drug. no need for prior art if you have a unique compound with a distinctly different MOA.
I am not inclined to defend James. I am pretty convinced that he...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.015(4.92%) |
Mkt cap ! $85.06M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 29.0¢ | $51.23K | 170.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 84041 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 35950 | 6 |
View Market Depth
| Last trade - 15.37pm 19/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |